Why let the truth get in the way of a good story? As long as Missling can still tap into vulture financing, this gravy train is going to keep rolling. How is our KEM analysis going? Wasn’t this supposed to improve our efficiency and effectiveness in bringing drugs to market? I guess our new AI strategic partnership will supposedly do this, but don’t hold your breath. I wonder how many analysts will be on August’s CC? My guess is it’ll be less than 1, that’s how EXCITED everyone is for our drug. Why let the truth get in the way of a good story.
Market Data 
Markets
AI
